Zsuzsanna Ament

Publications

• Uric Acid and Gluconic Acid as Predictors of Hyperglycemia and Cytotoxic Injury after Stroke
• Nucleosides Associated With Incident Ischemic Stroke in the REGARDS and JHS Cohorts
• Hypoxanthine is a pharmacodynamic marker of ischemic brain edema modified by glibenclamide
• Plasma Metabolites Link Dietary Patterns to Stroke Risk
• Gut microbiota-associated metabolites and risk of ischemic stroke in REGARDS
• Association of Circulating Metabolites With Racial Disparities in Hypertension and Stroke in the REGARDS Study
• Plasma Metabolites and Life’s Simple 7 in REGARDS
• Metabolic profiling of aortic stenosis and hypertrophic cardiomyopathy identifies mechanistic contrasts in substrate utilization
• Sex‐Associated Metabolites and Incident Stroke, Incident Coronary Heart Disease, Hypertension, and Chronic Kidney Disease in the REGARDS Cohort
• Associations Between Ultra-Processed Food Consumption and Adverse Brain Health Outcomes
• Acetylglutamine Differentially Associated with First-Time Versus Recurrent Stroke.
• Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease.
• Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke.
• Metabolite profiles and DNA methylation in metabolic syndrome: a two-sample, bidirectional Mendelian randomization.
• Metabolic basis to Sherpa altitude adaptation.
• Metabolomics dataset of PPAR-pan treated rat liver.
• Succinate links atrial dysfunction and cardioembolic stroke.
• Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis.
• PPAR-pan activation induces hepatic oxidative stress and lipidomic remodelling.
• Myc Expression Drives Aberrant Lipid Metabolism in Lung Cancer.
• Omega-3 Fatty Acids and Risk of Ischemic Stroke in REGARDS.
• The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet and Metabolites in Chronic Kidney Disease.
• Metabolic differences in ripening of Solanum lycopersicum 'Ailsa Craig' and three monogenic mutants.
• Workplace food purchases, dietary intake, and gut microbial metabolites in a secondary analysis of the ChooseWell 365 study.
• Machine Learning-Driven Metabolomic Evaluation of Cerebrospinal Fluid: Insights Into Poor Outcomes After Aneurysmal Subarachnoid Hemorrhage.
• A metabolomics investigation of non-genotoxic carcinogenicity in the rat.
• Odd Chain Fatty Acids; New Insights of the Relationship Between the Gut Microbiota, Dietary Intake, Biosynthesis and Glucose Intolerance.
• Integration of metabolomics, lipidomics and clinical data using a machine learning method.
• A targeted metabolomics assay for cardiac metabolism and demonstration using a mouse model of dilated cardiomyopathy.
• Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers.
• Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer.
• Targeted Metabolomics in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study